Abstract
This Frost & Sullivan research service titled Strategic Analysis of the South
African Diabetes Markets provides an overview of the South African healthcare
industry in the context of diabetes treatment drugs as divided between Type 1
and Type 2 diabetics. In this research, Frost & Sullivan' s expert analysts
thoroughly examine key industry challenges, drivers, restraints, and trends.
Revenue forecasts and strategic recommendations are also provided.
This analysis is available through our Pharmaceuticals and Biotechnology
Growth Partnership Services programme. With this programme, clients receive
industry-leading market research such as this, along with technical and
econometric data and many interactive features including Analyst Inquiry Time
and Client Councils.
View Cart
